Bal Pharma Ltd. - Research Center
524824 BALPHARMA Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | |
|---|---|---|---|---|---|
| Profit before tax | 9.80 | -9.08 | 4.41 | 8.45 | 8.59 |
| Net cashflow-operating activity | 10.24 | 21.57 | 9.10 | 12.57 | 6.36 |
| Net cash used in investing activity | -6.66 | -3.16 | -9.53 | -15.59 | -7.96 |
| Netcash used in fin. activity | -3.36 | -19.94 | 0.05 | 3.53 | 1.74 |
| Net inc/dec in cash and equivlnt | 0.21 | -1.52 | -0.38 | 0.51 | 0.15 |
| Cash and equivalnt begin of year | 0.68 | 2.20 | 2.58 | 2.07 | 4.46 |
| Cash and equivalnt end of year | 0.89 | 0.68 | 2.20 | 2.58 | 4.61 |
© 2022 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis